Sunshine Biopharma Inc. Operating Loss Carryforwards
Sunshine Biopharma Inc. (SBFM) had Operating Loss Carryforwards of $2.98 million as of 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2022-03-21
- 2021-12-31: Operating Loss Carryforwards $2.98M.
- 2020-12-31: Operating Loss Carryforwards $690.35K; Operating Loss Carryforwards as first filed $10.61M.
- 2019-12-31: Operating Loss Carryforwards $13.58M.
- 2018-12-31: Operating Loss Carryforwards $12.16M; Operating Loss Carryforwards as first filed $12.45M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2021-12-31 | $2.98M 10-K · filed 2022-03-21 | |
| 2020-12-31 | $690.35K 10-K · filed 2022-03-21 | $10.61M 10-K · filed 2021-03-30 |
| 2019-12-31 | $13.58M 10-K · filed 2020-05-01 | |
| 2018-12-31 | $12.16M 10-K · filed 2020-05-01 | $12.45M 10-K · filed 2019-04-12 |
| 2017-12-31 | $10.61M 10-K · filed 2019-04-12 | |
| 2016-12-31 | $9.61M 10-K · filed 2018-04-02 | |
| 2016-06-30 | $9.78M 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $9.39M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $11.45M 10-Q · filed 2016-11-14 | $9.08M 10-Q · filed 2016-05-09 |
| 2015-09-30 | $7.43M 10-Q · filed 2015-11-04 | |
| 2014-12-31 | $8.43M 10-Q · filed 2015-11-04 | |
| 2013-12-31 | $5.49M 10-K · filed 2014-03-19 | |
| 2012-12-31 | $3.00M 10-K · filed 2014-03-19 | |
| 2011-12-31 | $2.29M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |